{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:30:32Z","timestamp":1784867432080,"version":"3.55.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,3]]},"abstract":"<jats:p>\n                    Transient ischemic attack (TIA) is a brief neurological dysfunction without acute infarction, often preceding ischemic stroke. Although tools like the ABCD2 score aid early risk stratification, their predictive reliability is limited in emergency settings, creating a demand for new biomarkers. Nardilysin (NRDC) and neurogranin (Ng) have emerged as promising candidates due to their involvement in axonal maturation, synaptic plasticity, and neurorepair. However, their diagnostic utility in early TIA remains unclear. This prospective cohort study aimed to evaluate the association between serum NRDC and Ng levels and early outcomes in TIA. We hypothesized that these biomarkers, particularly NRDC due to its neurovascular repair function, could serve as early indicators in patients at risk. A total of 33 TIA patients (20 males; mean age: 65.97\u2005\u00b1\u200515.99) and 48 healthy controls (23 males; mean age: 66.85\u2005\u00b1\u20059.53) were recruited from the emergency department of a university-affiliated tertiary hospital in Ankara, T\u00fcrkiye, between June and December 2022. Groups were similar in age, sex, and body mass index. The control group had no known comorbidities such as hypertension or diabetes. Blood samples were collected within 6 hours of symptom onset and analyzed using ELISA. Clinical variables, ABCD2 scores, and outcomes (e.g., admission, discharge, 1-month mortality) were recorded. Statistical analysis included\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    -tests, chi-square, Mann\u2013Whitney\n                    <jats:italic toggle=\"yes\">U<\/jats:italic>\n                    , and receiver operating characteristic analysis using SPSS and Analyse-it. NRDC levels were significantly lower in TIA patients (4.65\u2005\u00b1\u20052.01 pg\/mL) than in controls (6.39\u2005\u00b1\u20052.32 pg\/mL,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001), showing moderate diagnostic accuracy (AUC\u2005=\u20050.720). Ng levels did not significantly differ between groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.5), and ABCD\n                    <jats:sup>2<\/jats:sup>\n                    scores showed no correlation with either biomarker. NRDC may be a promising early blood-based biomarker for TIA, particularly when imaging is inconclusive. Further studies are needed to validate these findings and clarify Ng\u2019s role.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044785","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:07:32Z","timestamp":1759781252000},"page":"e44785","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association of blood nardilysin and neurogranin levels with early outcomes in transient ischemic attack: A prospective cohort study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5879-7858","authenticated-orcid":false,"given":"Serhat","family":"Orun","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Tekirda\u011f Namik Kemal University, Tekirdag, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0299-1691","authenticated-orcid":false,"given":"Selahattin","family":"Guru","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8147-5379","authenticated-orcid":false,"given":"Esra","family":"Firat Oguz","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Ankara Bilkent City Hospital, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9261-2669","authenticated-orcid":false,"given":"Habibe Selmin","family":"Ozensoy","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260526","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1161\/STR.0000000000000418","article-title":"Diagnosis, workup, risk reduction of transient ischemic attack in the emergency department setting: a scientific statement from the American Heart Association.","volume":"54","author":"Amin","year":"2023","journal-title":"Stroke"},{"key":"R2-20260526","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association.","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"R3-20260526","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/1747493018823568","article-title":"Contemporary prognosis of transient ischemic attack patients: a systematic review and meta-analysis.","volume":"14","author":"Najib","year":"2019","journal-title":"Int J Stroke"},{"key":"R4-20260526","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1080\/00207454.2020.1835897","article-title":"External validations of the ABCD2 score in prediction of stroke risk after transient ischemic attack. A Tunisian hospital-based cohort study.","volume":"133","author":"Nizar","year":"2023","journal-title":"Int J Neurosci"},{"key":"R5-20260526","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.08.010","article-title":"Clinical features and functional outcome of stroke after transient ischemic attack.","volume":"22","author":"Hoshino","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R6-20260526","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","article-title":"Short-term prognosis after emergency department diagnosis of TIA.","volume":"284","author":"Johnston","year":"2000","journal-title":"JAMA"},{"key":"R7-20260526","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)66702-5","article-title":"A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack.","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"R8-20260526","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(07)60150-0","article-title":"Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack.","volume":"369","author":"Johnston","year":"2007","journal-title":"Lancet"},{"key":"R9-20260526","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1503\/cmaj.101668","article-title":"Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack.","volume":"183","author":"Perry","year":"2011","journal-title":"CMAJ"},{"key":"R10-20260526","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.annemergmed.2013.02.007","article-title":"In patients presenting with transient ischemic attack, does the ABCD(2) clinical prediction rule provide adequate risk stratification for clinical decision making in the emergency department?","volume":"62","author":"Lee","year":"2013","journal-title":"Ann Emerg Med"},{"key":"R11-20260526","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/emboj\/20.13.3342","article-title":"N\u2010arginine dibasic convertase is a specific receptor for heparin\u2010binding EGF\u2010like growth factor that mediates cell migration.","volume":"20","author":"Nishi","year":"2001","journal-title":"EMBO J"},{"key":"R12-20260526","doi-asserted-by":"crossref","first-page":"149961","DOI":"10.1016\/j.bbrc.2024.149961","article-title":"Nardilysin in vascular smooth muscle cells controls blood pressure via the regulation of calcium dynamics.","volume":"712-713","author":"Batbaatar","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-20260526","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/0929866043406508","article-title":"Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation.","volume":"11","author":"Hospital","year":"2004","journal-title":"Protein Pept Lett"},{"key":"R14-20260526","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00726-013-1499-8","article-title":"Nardilysin in human brain diseases: both friend and foe.","volume":"45","author":"Bernstein","year":"2013","journal-title":"Amino Acids"},{"key":"R15-20260526","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/nn.2438","article-title":"Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system.","volume":"12","author":"Ohno","year":"2009","journal-title":"Nat Neurosci"},{"key":"R16-20260526","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2008.03.050","article-title":"Ectodomain shedding of TNF-\u03b1 is enhanced by nardilysin via activation of ADAM proteases.","volume":"370","author":"Hiraoka","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-20260526","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/ncomms4224","article-title":"Critical roles of nardilysin in the maintenance of body temperature homoeostasis.","volume":"5","author":"Hiraoka","year":"2014","journal-title":"Nat Commun"},{"key":"R18-20260526","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2013.07.014","article-title":"Nardilysin prevents amyloid plaque formation by enhancing \u03b1-secretase activity in an Alzheimer\u2019s disease mouse model.","volume":"35","author":"Ohno","year":"2014","journal-title":"Neurobiol Aging"},{"key":"R19-20260526","doi-asserted-by":"crossref","first-page":"584743","DOI":"10.3389\/fnagi.2020.584743","article-title":"Neurogranin: a potential biomarker of neurological and mental diseases.","volume":"12","author":"Xiang","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"R20-20260526","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jnr.490260402","article-title":"Subtractive cDNA cloning of RC3, a rodent cortex-enriched mRNA encoding a novel 78 residue protein.","volume":"26","author":"Watson","year":"1990","journal-title":"J Neurosci Res"},{"key":"R21-20260526","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1523\/JNEUROSCI.10-12-03782.1990","article-title":"Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate.","volume":"10","author":"Represa","year":"1990","journal-title":"J Neurosci"},{"key":"R22-20260526","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s40520-019-01326-z","article-title":"A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer\u2019s disease and mild cognitive impairment.","volume":"32","author":"Mavroudis","year":"2020","journal-title":"Aging Clin Exp Res"},{"key":"R23-20260526","doi-asserted-by":"crossref","first-page":"105991","DOI":"10.1016\/j.nbd.2023.105991","article-title":"Neurogranin in Alzheimer\u2019s disease and ageing: a human post-mortem study.","volume":"177","author":"Saunders","year":"2023","journal-title":"Neurobiol Dis"},{"key":"R24-20260526","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13760-023-02202-4","article-title":"Stroke in Parkinson\u2019s disease: a review of epidemiological studies and potential pathophysiological mechanisms.","volume":"123","author":"Elfil","year":"2023","journal-title":"Acta Neurol Belg"},{"key":"R25-20260526","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.neurobiolaging.2013.08.028","article-title":"Nardilysin, ADAM10, and Alzheimer\u2019s disease: of mice and men.","volume":"35","author":"Bernstein","year":"2014","journal-title":"Neurobiol Aging"},{"key":"R26-20260526","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2017.06.002","article-title":"Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer\u2019s disease.","volume":"58","author":"Pereira","year":"2017","journal-title":"Neurobiol Aging"},{"key":"R27-20260526","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2015.12.013","article-title":"Neurogranin restores amyloid \u03b2-mediated synaptic transmission and long-term potentiation deficits.","volume":"277","author":"Kaleka","year":"2016","journal-title":"Exp Neurol"},{"key":"R28-20260526","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000502449","article-title":"Candidate biomarkers for the diagnosis of transient ischemic attack: a systematic review.","volume":"47","author":"Dolmans","year":"2019","journal-title":"Cerebrovasc Dis"},{"key":"R29-20260526","doi-asserted-by":"crossref","first-page":"106292","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106292","article-title":"Diagnostic and prognostic blood biomarkers in transient ischemic attack and minor ischemic stroke: an up-to-date narrative review.","volume":"31","author":"Foschi","year":"2022","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R30-20260526","doi-asserted-by":"crossref","first-page":"e947703","DOI":"10.12659\/MSM.947703","article-title":"Exploring the association between serum Neurogranin, Nardilysin, and ischemic stroke: a case-control study conducted in the emergency department.","volume":"31","author":"Ozensoy","year":"2025","journal-title":"Med Sci Monit"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:29:24Z","timestamp":1779805764000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":30,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044785","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2025-05-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}